Partnerships & Licensing

You bring the targets, we bring the platforms

We believe the best science moves forward through partnership. Our licensing runs on one premise: your success is our success. Whether you’re an emerging biotech or an established pharma, we structure licenses to fit your program.

How we approach licensing Aligned interests, in writing

inv-icon-balance
Mutual success

We structure deals so we do well when you do well, from preclinical work through commercialization.

inv-icon-earn
Full transparency

Clear visibility into IP ownership, data rights, payment timing, and terms. No surprises, no hidden terms.

inv-icon-vision
Low-friction documents

Licensing paperwork that’s easy for your team to read and process.

inv-icon-path
Built to fit

Structures that match your stage, budget, and goals, not a fixed template.

mAb Discovery Licensing Your monoclonal is yours

A monoclonal antibody from our discovery service is unencumbered. You own the sequences. There’s no license to sign.

No license required

B-Body® Licensing Accessible to academia, startups, and pharma alike

Most IP-protected platforms keep licensing out of reach for smaller teams. We lowered those barriers, so any group can build on B-Body. From the first term sheet to the executed agreement, you’ll have clear visibility into IP ownership, data rights, payment timing, and financial terms. No surprises, no hidden terms, and open communication for the life of the agreement.

All clinical/commercial B-Body licensing is managed by our partner, Twist Bioscience.

Research Use License
When

Included with every service project

What you get
  • Full rights to use the antibody for research
  • Valid until you take a clinical / commercial license

No milestones or royalties

Early Decision License
When

Take a one-year option within 6 months of signing your project contract. Renewable in one-year terms. Receive full license when you exercise and pay before the option expires

What you get
  • Full tech transfer of sequences and know-how to fast-track to IND
  • A full clinical/commercial license
  • Lower pricing if you exercise within the deadline
  • Most flexible: delay full licensing payment but retain access to discounted fee structure

No milestones or royalties

Standard License
When

Any time before IND submission

What you get
  • Pre-IND full tech transfer of sequences and know-how
  • A full clinical / commercial license
  • Decide in step with your IND submission

No milestones or royalties

Prefer to keep bispecific discovery in-house?

We offer site licensing for the B-Body discovery platform. We share the full platform IP and provide hands-on technology transfer to get your team running in your own facility. Annual research-use (RUO) site licenses let you generate leads against your targets, on your timeline, in your own infrastructure. When you’re ready for the clinic, site licensees move straight into the clinical/commercial licenses above.

T-Body® Licensing No two trispecific programs are the same

T-Body is a novel, premium platform, and the relationships around it are strategic and collaborative. So instead of a fixed menu, we offer a range of licensing structures built around your program.

Shared risk, shared reward. We understand the realities of drug development, so our programs share both the risk and the upside. Through co-discovery options, back-loaded payments, and performance-based milestones, we line up our interests with yours from preclinical work through commercialization.

Adapted to your needs. No two programs are alike, and we don’t treat them that way. You can structure a deal that fits your development timeline, therapeutic area, budget, risk tolerance, and commercial goals.

Co-discovery options

Build the program together from the start

Back-loaded payments

Weight the cost toward later, de-risked stages

Performance-based milestones

Tied to progress from preclinical to commercial

Get in touch Let's start the conversation

Our programs are flexible, and we want to learn about your situation. Tell our licensing team about your program and we’ll find a structure that works.

Your information is 100% confidential.

We don’t share your data with third parties, add you to marketing lists without permission, or contact you about anything other than this request. If your program requires an NDA, just say so. We can send one first if you’d like.